Burrill Starts Sangamo BioSciences (SGMO) at Market Outperform

Article Stock Quotes (1) Comments (0)

Burrill initiates coverage on Sangamo BioSciences (NASDAQ: SGMO) with a Market Outperform. PT $28.00.

"We believe Sangamo's innovative genome editing approach could provide novel and transformative therapeutics, which could revolutionize the treatment of genetic disorders," the analyst said.

For an analyst ratings summary and ratings history on Sangamo BioSciences click here. For more ratings news on Sangamo BioSciences click here.

Shares of Sangamo BioSciences closed at $8.56 yesterday, with a 52 week range of $4.01-$10.05.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
• UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
• Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold

Create E-mail Alert Related Categories

Hot New Coverage, New Coverage

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?